Cargando…

Future Approaches for Treating Chronic Myeloid Leukemia: CRISPR Therapy

SIMPLE SUMMARY: In the last two decades, the therapeutic landscape of several tumors have changed profoundly with the introduction of drugs against proteins encoded by oncogenes. Oncogenes play an essential role in human cancer and when their encoded proteins are inhibited by specific drugs, the tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vuelta, Elena, García-Tuñón, Ignacio, Hernández-Carabias, Patricia, Méndez, Lucía, Sánchez-Martín, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915349/ https://www.ncbi.nlm.nih.gov/pubmed/33557401 http://dx.doi.org/10.3390/biology10020118

Ejemplares similares

CRISPR/Cas9-Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML
por: Vuelta, Elena, et al.
Publicado: (2022)

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
por: García-Tuñón, Ignacio, et al.
Publicado: (2017)

Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency
por: García-Tuñón, Ignacio, et al.
Publicado: (2019)

A Potential Effect of Circadian Rhythm in the Delivery/Therapeutic Performance of Paclitaxel–Dendrimer Nanosystems
por: Albuquerque, Tânia, et al.
Publicado: (2023)

Granuloma Formation in a Cyba-Deficient Model of Chronic Granulomatous Disease Is Associated with Myeloid Hyperplasia and the Exhaustion of B-Cell Lineage
por: Prieto-Bermejo, Rodrigo, et al.
Publicado: (2021)

Chronic myeloid leukemia developing in treated acute promyelocytic leukemia
por: Abbasi, Abdul Muqtadir, et al.
Publicado: (2022)

Potential of ponatinib to treat chronic myeloid leukemia and acute lymphoblastic leukemia
por: Price, Kimberly E, et al.
Publicado: (2013)

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
por: Hochhaus, A., et al.
Publicado: (2020)

Renal tuberculosis in an imatinib-treated chronic myeloid leukemia
por: Chandra, Abhilash, et al.
Publicado: (2020)

Arterial hypertension assessment in a population with chronic myeloid leukemia
por: Roa-Chamorro, Ricardo, et al.
Publicado: (2021)

Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia
por: Alarcón-Payer, Carolina, et al.
Publicado: (2022)

Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future
por: Minciacchi, Valentina R., et al.
Publicado: (2021)

Chronic myeloid leukemia
por: Hantschel, Oliver
Publicado: (2019)

Chronic myeloid leukemia
por: Sauβele, Susanne
Publicado: (2018)

Practical Management of the Venetoclax-Treated Patient in Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
por: Waggoner, Matthew, et al.
Publicado: (2022)

Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia
por: Romo-González, Marta, et al.
Publicado: (2020)

Acute myeloid leukemia: current progress and future directions
por: Kantarjian, Hagop, et al.
Publicado: (2021)

Effect of Age on NK Cell Compartment in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors
por: Rodrigues-Santos, Paulo, et al.
Publicado: (2018)

Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib
por: Maruta, Shunsuke, et al.
Publicado: (2021)

Third-line therapy for chronic myeloid leukemia: current status and future directions
por: Cortes, Jorge, et al.
Publicado: (2021)

A Deeper Dive Into Advanced and Future Directions in Treating Patients With Acute Myeloid Leukemia
por: Kurtin, Sandra E., et al.
Publicado: (2018)

Tyrosine Kinase Inhibitors Available for Chronic Myeloid Leukemia: Efficacy and Safety
por: García-Gutiérrez, Valentín, et al.
Publicado: (2019)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Extramedullary Manifestations of Chronic Myelomonocytic Leukemia: Do We Treat like an Acute Myeloid Leukemia?
por: Pudasainee, Prasun, et al.
Publicado: (2019)

Antitumoral effect of Ocoxin on acute myeloid leukemia
por: Díaz-Rodríguez, Elena, et al.
Publicado: (2016)

Advances in treating acute myeloid leukemia
por: Showel, Margaret M., et al.
Publicado: (2014)

Chronic myeloid leukemia in India
por: Goldman, John M.
Publicado: (2013)

Bosutinib for Chronic Myeloid Leukemia
por: Breccia, Massimo, et al.
Publicado: (2015)

Chronic Myeloid Leukemia in India
por: Ganesan, Prasanth, et al.
Publicado: (2016)

Chronic Myeloid Leukemia in 2020
por: Hehlmann, Rüdiger
Publicado: (2020)

Chronic Myeloid Leukemia in 2007
por: Sessions, Jolynn
Publicado: (2007)

Targeted genome editing in acute lymphoblastic leukemia: a review
por: Montaño, Adrián, et al.
Publicado: (2018)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Cutaneous myeloid sarcoma associated with chronic myeloid leukemia
por: Vasconcelos, Erica Rodrigues de Araujo, et al.
Publicado: (2017)

Pediatric chronic myeloid leukemia in myeloid blast crisis
por: Dey, Biswajit, et al.
Publicado: (2023)

Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?
por: Elsayed, Marwa, et al.
Publicado: (2022)

An approach to the management of chronic myeloid leukemia in British Columbia
por: Forrest, D.L., et al.
Publicado: (2008)

Chronic phase of chronic myeloid leukemia presenting with myeloid sarcoma in an adolescent
por: Lee, Hee Jin, et al.
Publicado: (2020)

NKT-Like (CD3+CD56+) Cells in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors
por: Almeida, Jani-Sofia, et al.
Publicado: (2019)

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis
por: Orlandi, Ester M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8pvb8tdmjjrr65h5dide5k38jh